M

Mural Oncology

HealthCancer Biotech

A new cancer biotech company has been launched by the former CEO of Mural Oncology. The company has secured $225 million in venture capital funding to advance its cancer research and development efforts.

Total raised
Undisclosed
tracked to date
Latest round
$225M
Sep 9, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $225MSep 9, 2026
    Announcement ↗

Mural Oncology in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile